Affiliation:
1. Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Abstract
Background Although many treatments for advanced gastric cancer have been developed, systemic therapy remains elusive. Methods The author reviewed data on recent phase II and III trials of the main new agents and combinations. Results Chemotherapy appears to improve survival of patients with advanced disease, albeit slightly. New drugs that might improve response rates and survival include the taxanes. Conclusions New combinations, including the taxanes, must be designed and evaluated to further improve the outcome for patients with advanced gastric cancer.
Subject
Oncology,Hematology,General Medicine
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献